Urooj Shahzadi
Department of Chemistry, University of Agriculture, Faisalabad, PakistanPublications
-
Research Article
In Silico Molecular Docking and Admet Evaluation for Investigating the Anti-Cancer Potential of Ketoprofen Amides Against Cyclooxygenase-2 (Cox-2)
Author(s): Muhammad Zeeshan*, Sidra Batool, Muhammad Usman Alvi, Zarif Gul, Maryam Ahmed, Urooj Shahzadi and Hassan Abbas
Many epithelial cancers overexpress the inducible cyclooxygenase-2 COX-2, which is thought to be the cause of NSAID’s antitumor effects. While ketoprofens (Ket) are well-known NSAIDs and analgesics, their anticancer potential has not yet gotten much attention, despite the fact that they are used to treat mild to moderate pain, fever, and inflammation. Effective drugs can be expensive, time-consuming, and labor intensive to introduce in a traditional or customary method. Contrarily, computer-aided drug design, commonly referred to as In Silico drug design, is a relatively recent method for high-throughput screening of a vast database of chemicals. By producing hits for lead compounds in less time and at a lower cost, the In Silico virtual screening technique assists in the development of innovative medications. The compound 1 shows the least bindi.. Read More»
DOI: 10.4303/JDAR/236218